Yan et al. found that TIM3 on CD14+ monocytes might act as a novel biological marker for diabetes duration in type 2 diabetes mellitus [13], which is consistent with the costimulatory properties of this molecule. This evidence concerns the gene HAVCR2 and type 2 diabetes mellitus.